Nantkwest

Nantkwest

World Rank (Aug-2026)
6535
World Rank (Jan-05-2024)
6,535
World Rank (Jul-30-2023)
6,535
World Rank (Jan-07-2022)
6,535
World Rank (Jan-01-2021)
6,535
Market Cap (Jan-01-2021)
1.448 Billion USD
Headquarters Country
USA
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
113 Million USD
Annual Operating Income in USD
-256 Million USD
Annual Net Income in USD
-351 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
502 Million USD
Total Liabilities in USD
1,001 Million USD
Total Equity in USD
-500 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
NANTKWEST
Company Profile
NantKwest is an innovative Clinical Stage Immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. It is having 161 employees as on 2019. The headquarters is in USA.
Founded Year
2002
IPO Year
2015
Stock Exchange
Nasdaq

Share